RPG Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 197.44 | 174.15 | 258.05 |
| Operating Expense | 142.65 | 133.45 | 117.60 |
| Net Profit | 36.85 | 26.29 | 117.35 |
| Net Profit Margin | 18.66 | 15.10 | 45.48 |
| Earning Per Share | 22.28 | 15.90 | 70.96 |
| EBIDTA | 53.75 | 40.63 | 140.38 |
| Effective Tax Rate | 21.10 | 22.29 | 12.45 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 197.44 |
| Operating Expense | 142.65 |
| Net Profit | 36.85 |
| Net Profit Margin | 18.66 |
| Earning Per Share | 22.28 |
| EBIDTA | 53.75 |
| Effective Tax Rate | 21.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 653.43 | 582.05 | 512.81 |
| Operating Expenses Annual | 493.78 | 453.90 | 410.12 |
| Operating Profit Annual | 254.93 | 135.36 | 107.49 |
| Interest Annual | 0.62 | 0.45 | 0.31 |
| Depreciation | 14.83 | 10.41 | 8.71 |
| Net Profit Annual | 183.24 | 87.66 | 67.64 |
| Tax Annual | 49.64 | 30.18 | 24.04 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 653.43 |
| Operating Expenses Annual | 493.78 |
| Operating Profit Annual | 254.93 |
| Interest Annual | 0.62 |
| Depreciation | 14.83 |
| Net Profit Annual | 183.24 |
| Tax Annual | 49.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 19.72 | 24.82 | 56.94 |
| Cash Flow from Operations | 77.86 | 94.36 | 90.82 |
| Cash Flow from Investing | -41.80 | -79.15 | -105.81 |
| Cash Flow from Financing | -27.08 | -20.31 | -17.12 |
| Cash Flow at the End | 28.70 | 19.72 | 24.83 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 19.72 |
| Cash Flow from Operations | 77.86 |
| Cash Flow from Investing | -41.80 |
| Cash Flow from Financing | -27.08 |
| Cash Flow at the End | 28.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 26 | 23.43 | 21.12 |
| PBIT Margin (%) | 22.72 | 20.49 | 18.10 |
| PBT Margin (%) | 8.43 | 6.26 | 2.36 |
| Net PROFIT Margin (%) | 28.04 | 15.06 | 13.19 |
| Return On Networth / Equity (%) | 25.53 | 25.69 | 24.01 |
| Return On Networth /Employed (%) | 32.28 | 34.25 | 32.15 |
| Return On Assets (%) | 39.82 | 25.15 | 23.48 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.42 | 1.67 | 1.78 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 26 |
| PBIT Margin (%) | 22.72 |
| PBT Margin (%) | 8.43 |
| Net PROFIT Margin (%) | 28.04 |
| Return On Networth / Equity (%) | 25.53 |
| Return On Networth /Employed (%) | 32.28 |
| Return On Assets (%) | 39.82 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 183.94 | 125.06 | 134.67 |
| Total Current Assets Annual | 465.25 | 298.09 | 264.05 |
| Non Current Assets Annual | 192.56 | 214.78 | 155.30 |
| Total Shareholders Funds Annual | 530.53 | 374.85 | 307.60 |
| Total Assets Annual | 657.81 | 512.87 | 419.35 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 183.94 |
| Total Current Assets Annual | 465.25 |
| Non Current Assets Annual | 192.56 |
| Total Shareholders Funds Annual | 530.53 |
| Total Assets Annual | 657.81 |
No Data Availabe
